Location: London, UK
Start Date: April 24, 2019
End Date: April 25, 2019
AllSeq Discount Code: BIOLOGICSALLSEQ20 (20%)
For Academics and Pharma/Biotech companies only. Contact Angela (email@example.com) for further instructions.
Twitter Hashtag: #Biologics19
Oxford Global is proud to present our 6th Annual Biosimilars & Biobetters Congress to be held on the 24 – 25 April 2019 in London. The Biologics Series also includes our co-located 12th Annual Proteins & Antibodies and 6th Annual Peptides Congresses which combined bring together over 400 leading experts.
The congress starts with discussions in the key areas of marketing biosimilars such as commercialisation and pricing strategies. The first day also covers talks that tackle the issue of regulations and standards in the European market.
Following the increased demand to prove interchangeability with current biologics to increase market penetration, the second day focuses on the clinical development, manufacturing and analytics of biosimilars. Day two includes critical talks on clinical trials and how they can help showcase interchangeability and to test safety and efficacy.
Key talks include:
- Designing and Conducting Clinical Trials For Biosimilars – Ekkehard Brockstedt, TCM Biosimilars, Corp. Div. Medicine, Boehringer Ingelheim
- Project Management for Biosimilars – From Inception Through To Approval – Anjan Selz, Vice President, Head of Biosimilars, EMEA, Lupin
- How to Fight Against Others Biosimilars On The Field – Julián Sanz, Biologics Regional Access Manager (RAM), Biosimilars, Biogen
View the agenda: https://bit.ly/2X81tat
For further information, prices and discounts please contact firstname.lastname@example.org